SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ)

$0.4494 0.0015 (0.3349%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 72

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) News Sources

Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm

17-02-2026

yahoo.com

Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform

25-02-2026

yahoo.com

Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept

02-03-2026

yahoo.com

Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price

16-03-2026

yahoo.com

Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026

19-03-2026

yahoo.com

Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration

01-04-2026

yahoo.com

Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities

06-04-2026

yahoo.com

Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing

24-04-2026

yahoo.com

Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe

15-05-2026

yahoo.com

Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility

20-05-2026

yahoo.com

SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) Sentiment Trend

0 25 50 75 100 73 71 57 58 85 91 83 81 79 37 17-02-2026 25-02-2026 02-03-2026 16-03-2026 19-03-2026 01-04-2026 06-04-2026 24-04-2026 15-05-2026 20-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) FAQs

toggle

What is the current price of SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ)?

The current price of SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) is $0.4494.


toggle

SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) absolute price change since previous trading day?

The absolute price change of SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) since the previous trading day is $0.0015.


toggle

SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) percentage price change since previous trading day?

The percentage price change of SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) since the previous trading day is 0.3349%.


toggle

What is the most recent average sentiment score for SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ)?

The most recent average sentiment score for SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) is 72 out of 100.


toggle

What is the most recent average sentiment for SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ)?

The most recent sentiment for SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) is .


SEC-8K** Filing Available For SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.